Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Monogram Technologies Inc.

Market Cap 24Cr 21Cr 19Cr 18Cr 34Cr 2.32TCr 35Cr 229.11Cr 89Cr 1.13TCr 91Cr 90Cr 3.91TCr P/E Ratio 2023
-5.61x
P/E Ratio 2024 -4.73x
Enterprise Value 23Cr 20Cr 18Cr 17Cr 32Cr 2.17TCr 32Cr 214.71Cr 84Cr 1.06TCr 86Cr 84Cr 3.66TCr EV / Sales 2023
25,75,22,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 2.56
Extreme 2.56
6.42
3 years 1.53
Extreme 1.53
6.55
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
07/25/07Issuer sale

Chief Executive Officer

55,66,330 13.6993%
07/25/07Issuer sale

Director

8,000 0.0197%
07/25/07Issuer sale

Chief Financial Officer

4,11,385 1.0125%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+126.84%+57.89% 24Cr
+2.28%+2.25%-17.86%+11.65% 12TCr
-0.31%-1.22%+2.12%-4.39% 1.29TCr
+1.96%+1.33%+29.77%+89.24% 729.48Cr
+1.87%-3.51%-46.74%-69.06% 411.68Cr
+2.06%+5.59%+11.04%+33.01% 249.16Cr
+5.46%+10.30%-16.96%-14.78% 170.1Cr
+1.67%-6.39%+3.63%-11.43% 163.04Cr
-8.89%-8.45%+165.17%+112.14% 148.75Cr
Average +0.47%+0.95%+28.56%+22.70% 1.66TCr
Weighted average by Cap. +1.93%+1.38%-11.81%+12.72%

Financials

2023 2024
Net sales 0.36 0.32 0.29 0.27 0.51 34.69 0.52 3.43 1.34 16.89 1.37 1.34 58.47 -
Net income -1.37Cr -1.19Cr -1.09Cr -1.02Cr -1.92Cr -130.65Cr -1.95Cr -13Cr -5.04Cr -64Cr -5.16Cr -5.05Cr -220.19Cr -1.63Cr -1.41Cr -1.3Cr -1.22Cr -2.28Cr -155.2Cr -2.31Cr -15Cr -5.98Cr -76Cr -6.13Cr -6Cr -261.56Cr
Net Debt -1.31Cr -1.13Cr -1.04Cr -97.57L -1.83Cr -124.49Cr -1.86Cr -12Cr -4.8Cr -61Cr -4.92Cr -4.81Cr -209.8Cr -1.53Cr -1.32Cr -1.22Cr -1.14Cr -2.14Cr -145.67Cr -2.17Cr -14Cr -5.62Cr -71Cr -5.75Cr -5.63Cr -245.51Cr
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
27
  1. Stock Market
  2. Stocks
  3. MGRM Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!